Seven Point Equity Partners

Tom Burchill and Mark Kammert lead the investment team and have directed over $1 billion in private equity transactions over 30 years (per firm website). They oversee deal origination, structuring, and portfolio governance, with each acquisition paired to a specific Operating Partner who takes a board seat or management role.

Seven Point does not detail its origination process publicly, but its website emphasizes relationships with intermediaries, management teams, and co-owners. The firm’s Operating Partner network — over a dozen executives with deep industrial sector connections — likely generates proprietary looks at complex situations and corporate carve-outs that fall below institutional auction thresholds.

Seven Point is structured as a private equity firm managing non-institutional, patient capital. It is not a single-family office, though its limited-partner base avoids institutional fund-of-funds, giving it unusual duration flexibility.

Seven Point invests directly in control buyouts and complex situations; there is no indication of fund-of-fund commitments. All disclosed activity — platform acquisitions, add-ons, and the RS7 Continuation Fund — involves direct company-level investment.

The firm targets control buyouts, growth equity, and complex situations in middle-market companies, typically with $25 million to $300 million in revenue and EBITDA from negative to $30 million. It does not invest in seed-stage or venture-backed startups.

The firm states that its capital is non-institutional, but does not disclose specific limited partners. This structure allows patient holding periods and a focus on multiples of invested capital rather than short-term IRRs (per firm website).

Yes — the Seven Point Foundation invests in community projects in regions where portfolio companies operate. Each year operating businesses and the foundation sponsor local initiatives, though the foundation is legally separate from the investment firm.